Evidence map›Paper›PMID 39774246›Full record

ReviewNature reviews. Neurology2025

Inclusion in neurological research: empowering people living with neurological diseases.

Maria Teresa Ferretti, Maria Bonaria Uccheddu, Richelle Flanagan, Iracema Leroi, Elena Moro

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The scope and impact of Walking the Talk for Dementia 2024.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maria Teresa FerrettiCenter for Alzheimer Research, Karolinska Institute, Stockholm, Sweden. mariateresa.ferretti@gmail.com.ORCID 0000-0003-0459-9615
Maria Bonaria UcchedduAssociazione Italiana Miastenia, Milan, Italy.ORCID 0009-0007-8188-8310
Richelle FlanaganMy Moves Matter, Dublin, Ireland.
Iracema LeroiSchool of Medicine, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0003-1822-3643
Elena MoroDivision of Neurology, CHU of Grenoble, Grenoble Alpes University, Grenoble, France.ORCID 0000-0002-7968-5908

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The value of involving people living with diseases in the research process is increasingly recognized by professional associations and regulatory agencies alike. Patient contributions range from disease prevention and diagnosis to medication planning, and from advocacy to guideline production and clinical trial design. Thanks to the efforts of activists and advocates, new models of patient inclusion in medical research are being developed to replace outdated non-participative and tokenistic paradigms. New modalities of patient participation in research - for example, the introduction of patient experts, who work closely with researchers and clinicians - have progressively empowered individuals who are living with diseases. In this Perspective, we provide an overview of the current status of patient involvement in medical research, with a specific focus on neurology. We also discuss the existing and future roles of patient experts in neurological research.

Indexed as

Biomedical ResearchEmpowermentNervous System DiseasesNeurologyPatient ParticipationHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.